Biovitrum, Cambridge Bio Ltd. deal

Biovitrum will acquire Cambridge Biotechnology for an undisclosed sum. Cambridge Biotechnology is developing compounds for obesity, pain and inflammation, while Biovitrum develops compounds for metabo...